Stopped early
The ROB-OSTIAL Study
NCT05634538 · Siemens Healthineers Endovascular Robotics, Inc. · Updated 4 June 2025
- What is being tested
- Robotic-assisted PCI with Corpath GRX® System; Standard PCI
- For
- Coronary Artery Disease
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 1 people. The full rules are on the registry page.
- Where
- Italy
- When
- Starts or started 30 March 2023, ends 8 May 2023. Registered 2 Dec 2022.
- Results
- Posted on the registry on 4 June 2025.
In the researchers' words
The purpose of this study is to compare the accuracy of robotic-assisted percutaneous coronary intervention (PCI) using the CorPath GRX® System, versus standard PCI when treating ostial lesions. CorPath GRX System (the Device) is a robotic-like device that is cleared for the remote delivery and control of heart catheterization devices. It helps doctors insert and move heart catheters (a thin, flexible tube) and similar types of devices inside patients blood vessels to treat the blockage in their heart. The results will help to evaluate whether procedures using the CorPath GRX result in more accurate stenting (placing of a tube to keep heart vessel open) compared to standard PCI.
Sites
- Maria Cecilia HospitalCotignola, RA, Italy